PLIN2 report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
macrophage	37 studies	45% ± 21%	Explore
mast cell	29 studies	50% ± 21%	Explore
endothelial cell	25 studies	29% ± 11%	Explore
classical monocyte	24 studies	35% ± 12%	Explore
fibroblast	22 studies	33% ± 17%	Explore
non-classical monocyte	22 studies	34% ± 11%	Explore
natural killer cell	18 studies	23% ± 7%	Explore
monocyte	17 studies	37% ± 17%	Explore
CD4-positive, alpha-beta T cell	14 studies	25% ± 6%	Explore
conventional dendritic cell	13 studies	31% ± 15%	Explore
regulatory T cell	13 studies	22% ± 5%	Explore
CD8-positive, alpha-beta T cell	11 studies	21% ± 4%	Explore
myeloid cell	11 studies	44% ± 16%	Explore
epithelial cell	11 studies	36% ± 18%	Explore
endothelial cell of vascular tree	10 studies	25% ± 10%	Explore
T cell	9 studies	24% ± 7%	Explore
dendritic cell	9 studies	30% ± 9%	Explore
adipocyte	9 studies	33% ± 14%	Explore
alveolar macrophage	8 studies	59% ± 19%	Explore
connective tissue cell	8 studies	31% ± 13%	Explore
epithelial cell of proximal tubule	7 studies	38% ± 14%	Explore
mature NK T cell	7 studies	24% ± 6%	Explore
enterocyte	7 studies	33% ± 8%	Explore
pericyte	7 studies	41% ± 24%	Explore
mucosal invariant T cell	7 studies	21% ± 5%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	21% ± 5%	Explore
leukocyte	6 studies	32% ± 12%	Explore
neutrophil	6 studies	44% ± 18%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	21% ± 4%	Explore
gamma-delta T cell	6 studies	28% ± 13%	Explore
endothelial cell of lymphatic vessel	5 studies	27% ± 7%	Explore
mononuclear phagocyte	5 studies	35% ± 11%	Explore
capillary endothelial cell	5 studies	26% ± 8%	Explore
smooth muscle cell	5 studies	20% ± 4%	Explore
adventitial cell	5 studies	22% ± 2%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	28% ± 12%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	20% ± 4%	Explore
hepatocyte	5 studies	53% ± 19%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	19% ± 2%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	21% ± 2%	Explore
glomerular endothelial cell	4 studies	40% ± 13%	Explore
abnormal cell	4 studies	40% ± 19%	Explore
innate lymphoid cell	4 studies	28% ± 11%	Explore
CD16-positive, CD56-dim natural killer cell, human	4 studies	21% ± 4%	Explore
mesothelial cell	4 studies	21% ± 5%	Explore
inflammatory macrophage	4 studies	39% ± 21%	Explore
erythroblast	4 studies	26% ± 6%	Explore
intermediate monocyte	4 studies	38% ± 19%	Explore
astrocyte	4 studies	19% ± 2%	Explore
T follicular helper cell	4 studies	22% ± 7%	Explore
CD4-positive, alpha-beta memory T cell	4 studies	28% ± 7%	Explore
basal cell	4 studies	25% ± 7%	Explore
B cell	3 studies	16% ± 1%	Explore
myofibroblast cell	3 studies	25% ± 9%	Explore
extravillous trophoblast	3 studies	80% ± 13%	Explore
placental villous trophoblast	3 studies	62% ± 26%	Explore
CD16-negative, CD56-bright natural killer cell, human	3 studies	25% ± 2%	Explore
type II pneumocyte	3 studies	28% ± 13%	Explore
tissue-resident macrophage	3 studies	45% ± 19%	Explore
endothelial cell of sinusoid	3 studies	40% ± 29%	Explore
CD4-positive helper T cell	3 studies	30% ± 8%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	29% ± 4%	Explore
granulocyte	3 studies	73% ± 15%	Explore
group 3 innate lymphoid cell	3 studies	27% ± 14%	Explore
double negative thymocyte	3 studies	25% ± 7%	Explore
secretory cell	3 studies	24% ± 7%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
lung	12 studies	28% ± 11%	Explore
peripheral blood	9 studies	23% ± 8%	Explore
intestine	9 studies	19% ± 6%	Explore
liver	9 studies	29% ± 9%	Explore
kidney	7 studies	29% ± 11%	Explore
uterus	6 studies	23% ± 5%	Explore
placenta	4 studies	50% ± 23%	Explore
breast	4 studies	20% ± 4%	Explore
adipose	3 studies	36% ± 13%	Explore
adrenal gland	3 studies	25% ± 8%	Explore
prostate	3 studies	24% ± 7%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
liver	99%	25346.98	223 / 226	100%	173.38	404 / 406
breast	97%	41135.90	446 / 459	92%	44.35	1024 / 1118
lung	95%	12173.09	547 / 578	86%	44.79	993 / 1155
bladder	86%	9752.14	18 / 21	93%	57.77	467 / 504
skin	83%	9099.95	1493 / 1809	88%	47.90	413 / 472
kidney	74%	9750.63	66 / 89	90%	451.43	814 / 901
intestine	54%	4136.84	517 / 966	88%	44.60	464 / 527
uterus	66%	4216.98	113 / 170	68%	35.69	310 / 459
ovary	45%	2863.03	81 / 180	80%	35.01	345 / 430
thymus	38%	2159.90	250 / 653	86%	28.89	520 / 605
adrenal gland	94%	11006.79	242 / 258	28%	14.51	64 / 230
stomach	32%	2051.76	114 / 359	85%	42.11	243 / 286
ureter	0%	0	0 / 0	100%	15.54	1 / 1
adipose	100%	55507.98	1203 / 1204	0%	0	0 / 0
muscle	99%	26259.39	795 / 803	0%	0	0 / 0
lymph node	0%	0	0 / 0	97%	46.72	28 / 29
pancreas	4%	188.42	14 / 328	89%	41.28	158 / 178
esophagus	30%	1837.67	429 / 1445	63%	22.02	115 / 183
prostate	20%	1544.50	48 / 245	65%	16.65	325 / 502
heart	73%	10935.03	627 / 861	0%	0	0 / 0
peripheral blood	72%	25204.07	670 / 929	0%	0	0 / 0
spleen	61%	3216.61	148 / 241	0%	0	0 / 0
blood vessel	59%	7079.72	793 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	51%	14.16	41 / 80
tonsil	0%	0	0 / 0	49%	11.27	22 / 45
brain	4%	233.78	113 / 2642	44%	19.07	310 / 705
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0